Biogen Inc. buy UBS Group AG
Start price
24.07.23
/
50%
€249.60
Target price
24.07.24
€302.51
Performance (%)
-16.51%
End price
25.07.24
€208.40
Summary
This prediction ended on 25.07.24 with a price of €208.40. The prediction for Biogen Inc. disappointed with a performance of -16.51%. UBS_Group_AG has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 2.556% | 2.556% | 47.661% |
| iShares Core DAX® | 0,30 % | 4,70 % | 4,54 % |
| iShares Nasdaq 100 | 0,43 % | 12,26 % | 31,98 % |
| iShares Nikkei 225® | 1,63 % | 12,62 % | 43,26 % |
| iShares S&P 500 | 0,57 % | 7,79 % | 23,48 % |
Comments by UBS_Group_AG for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at UBS Group AG from $346.00 to $335.00. They now have a "buy" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten